Evaluation of SNA001, a Novel Recombinant Human Thyroid Stimulating Hormone Injection, in Patients With Differentiated Thyroid Carcinoma

SNA001 is a novel recombinant human thyroid stimulating hormone (rhTSH). rhTSH has long been approved in several countries to facilitate monitoring and ablation of thyroid carcinoma without hypothyroidism caused by thyroid hormone withdrawal (THW). To assess the safety, tolerance, pharmacokinetic an...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Yushen, Xu, Hongrong, Yang, Yanling, Xiu, Yan, Hu, Pengcheng, Liu, Min, Wang, Xiangqing, Song, Jun, Di, Yan, Wang, Jian, Zhang, Xiaoxia, Xu, Tao, Li, Xuening, Shi, Hongcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927955/
https://www.ncbi.nlm.nih.gov/pubmed/33679603
http://dx.doi.org/10.3389/fendo.2020.615883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927955/
https://www.ncbi.nlm.nih.gov/pubmed/33679603
http://dx.doi.org/10.3389/fendo.2020.615883

Ejemplares similares